CXCL8 and colonic neoplasm: Stattic, a small molecule inhibitor, has been shown to selectively inhibit STAT3 through the SH2 domain regardless of the STAT3 activation state.38 We further confirmed the effect of STAT3 activation on IL‐8 expression in colon cancer cells with Stattic (Figure 4).